Study tests best way to protect drug users from HIV and cure hepatitis c
NCT ID NCT03981445
Summary
This study aims to find the best way to provide HIV prevention medication and hepatitis C treatment to people who inject drugs. It compares two approaches: getting care directly at a drug treatment or needle exchange site versus being referred to a specialist clinic. Researchers will measure how well participants stick to their HIV prevention plan and how many are cured of hepatitis C.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAVENOUS DRUG USAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
-
Miami
Miami, Florida, 33136, United States
-
Montreal
Montreal, Quebec, Canada
Conditions
Explore the condition pages connected to this study.